119 related articles for article (PubMed ID: 36196999)
1. Independent prognostic value of left ventricular mass index in patients with light-chain amyloidosis.
Huang H; He H; Qin Y; Du J; Song J
Acta Cardiol; 2022 Nov; 77(9):815-821. PubMed ID: 36196999
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
[TBL] [Abstract][Full Text] [Related]
3. Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis.
Milani P; Dispenzieri A; Scott CG; Gertz MA; Perlini S; Mussinelli R; Lacy MQ; Buadi FK; Kumar S; Maurer MS; Merlini G; Hayman SR; Leung N; Dingli D; Klarich KW; Lust JA; Lin Y; Kapoor P; Go RS; Pellikka PA; Hwa YL; Zeldenrust SR; Kyle RA; Rajkumar SV; Grogan M
Circ Cardiovasc Imaging; 2018 May; 11(5):e006588. PubMed ID: 29752392
[TBL] [Abstract][Full Text] [Related]
4. [The prognostic value of morphological and functional parameters of cardiac magnetic resonance in patients with systemic light chain amyloidosis].
Miao FJ; Tang CX; Chen WC; Ren GS; Guo JZ; Zhao L; Zhou XY; Zhang LJ; Huang XH
Zhonghua Yi Xue Za Zhi; 2023 Feb; 103(7):506-512. PubMed ID: 36800774
[No Abstract] [Full Text] [Related]
5. Echocardiographic phenotype for refined risk stratification and treatment selection in light chain amyloidosis with heart failure.
Yang H; Li R; Ma F; Liu Y; He X; Yang Q; Wang DW; Zeng H; Wang H
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8415-8427. PubMed ID: 37084113
[TBL] [Abstract][Full Text] [Related]
6. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
Damy T; Jaccard A; Guellich A; Lavergne D; Galat A; Deux JF; Hittinger L; Dupuis J; Frenkel V; Rigaud C; Plante-Bordeneuve V; Bodez D; Mohty D
Amyloid; 2016 Sep; 23(3):194-202. PubMed ID: 27647161
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation.
Pun SC; Landau HJ; Riedel ER; Jordan J; Yu AF; Hassoun H; Chen CL; Steingart RM; Liu JE
J Am Soc Echocardiogr; 2018 Jan; 31(1):64-70. PubMed ID: 29111123
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.
Papathanasiou M; Jakstaite AM; Oubari S; Siebermair J; Wakili R; Hoffmann J; Carpinteiro A; Hagenacker T; Thimm A; Rischpler C; Kessler L; Rassaf T; Luedike P
ESC Heart Fail; 2022 Jun; 9(3):1740-1748. PubMed ID: 35178887
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of light chain amyloidosis: a multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy.
Aurich M; Bucur J; Vey JA; Greiner S; Aus dem Siepen F; Hegenbart U; Schönland S; Katus HA; Frey N; Mereles D
Open Heart; 2023 Jul; 10(2):. PubMed ID: 37463823
[TBL] [Abstract][Full Text] [Related]
10. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.
Kumar S; Dispenzieri A; Lacy MQ; Hayman SR; Buadi FK; Colby C; Laumann K; Zeldenrust SR; Leung N; Dingli D; Greipp PR; Lust JA; Russell SJ; Kyle RA; Rajkumar SV; Gertz MA
J Clin Oncol; 2012 Mar; 30(9):989-95. PubMed ID: 22331953
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
[TBL] [Abstract][Full Text] [Related]
12. Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis.
Wan K; Sun J; Han Y; Luo Y; Liu H; Yang D; Cheng W; Zhang Q; Zeng Z; Chen Y
Heart Vessels; 2018 Feb; 33(2):170-179. PubMed ID: 28840397
[TBL] [Abstract][Full Text] [Related]
13. Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis.
Kim D; Lee GY; Choi JO; Kim K; Kim SJ; Jeon ES
Sci Rep; 2019 May; 9(1):7746. PubMed ID: 31123293
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic study.
Pradel S; Magne J; Jaccard A; Fadel BM; Boulogne C; Salemi VMC; Damy T; Aboyans V; Mohty D
Int J Cardiovasc Imaging; 2019 May; 35(5):845-854. PubMed ID: 30623354
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation.
Al Saleh AS; Sidiqi MH; Muchtar E; Buadi FK; Dispenzieri A; Warsame R; Lacy MQ; Dingli D; Gonsalves WI; Kourelis TV; Hogan WJ; Hayman SR; Kapoor P; Kumar SK; Gertz MA
Biol Blood Marrow Transplant; 2020 Aug; 26(8):1402-1405. PubMed ID: 32422250
[TBL] [Abstract][Full Text] [Related]
16. Right ventricular longitudinal strain: a tool for diagnosis and prognosis in light-chain amyloidosis.
Uzan C; Lairez O; Raud-Raynier P; Garcia R; Degand B; Christiaens LP; Rehman MB
Amyloid; 2018 Mar; 25(1):18-25. PubMed ID: 29260587
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors in light-chain cardiac amyloidosis: a retrospective analysis].
Okumura H; Sato S; Kamata W; Tamai Y
Rinsho Ketsueki; 2021; 62(11):1576-1582. PubMed ID: 34866079
[TBL] [Abstract][Full Text] [Related]
18. Association of Cancer Antigen 125 with Long-Term Prognosis in Light-Chain Cardiorenal Amyloidosis.
Wu B; Shi J; Yu F; Wu Y; Tao X; Xuan T; Yang J; Wang X
Cardiorenal Med; 2023; 13(1):19-25. PubMed ID: 36215974
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.
Kristen AV; Rosenberg M; Lindenmaier D; Merkle C; Steen H; Andre F; Schönland SO; Schnabel PA; Schuster T; Röcken C; Giannitsis E; Katus HA; Frey N
Amyloid; 2014 Sep; 21(3):202-10. PubMed ID: 25007036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]